Drugs Made In America Acquisition II Corp. Right (DMIIR) Stock Price
Drugs Made In America Acquisition II Corp. Right (NASDAQ: DMIIR) last traded at $0.0910, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from Drugs Made In America Acquisition II Corp. Right’s own filings and are restated only when a new one is published.
Drugs Made In America Acquisition II Corp. Right (DMIIR) company overview
Drugs Made In America Acquisition II Corp. Right trades on NASDAQ under the ticker DMIIR. Its market capitalisation is $5.80 million.
DMIIR valuation
Valuation measures for Drugs Made In America Acquisition II Corp. Right, derived from the latest quote and its most recent SEC filing.
Market cap
$5.80M
Enterprise value
$23.77M
DMIIR financials
Trailing-twelve-month figures tagged in Drugs Made In America Acquisition II Corp. Right's XBRL filings with the SEC.
Net income (TTM)
$13.02M
Cash
$175.0K
DMIIR trading statistics
Range and volume for DMIIR over the past 52 weeks.
52-week high
$0.100
52-week low
$0.0900
Volume
108
Average volume
108
Previous close
$0.0910
Drugs Made In America Acquisition II Corp. Right (DMIIR) FAQs
What is the DMIIR stock price today?
Drugs Made In America Acquisition II Corp. Right (DMIIR) last traded at $0.09, up 0.00% on the session. FurlPay quotes DMIIR from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is DMIIR listed on?
Drugs Made In America Acquisition II Corp. Right is listed on NASDAQ under the ticker symbol DMIIR.
What is Drugs Made In America Acquisition II Corp. Right's market cap?
Drugs Made In America Acquisition II Corp. Right has a market capitalisation of $5.80 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is DMIIR's 52-week range?
Over the past 52 weeks DMIIR has traded between $0.09 and $0.10.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0002040475), period ending 2026-06-30.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.
DMIIR Stock Price & Quote | Drugs Made In America Acquisition II Corp. Right | FurlPay